Reduced XPC DNA repair gene mRNA levels in clinically normal parents of xeroderma pigmentosum patients

Carcinogenesis

Volumn 27, Issue 1, 2006, Pages 84-94

  Khan, Sikandar G ^a   Oh, Kyu Seon ^a   Shahlavi, Tala ^a,h   Ueda, Takahiro ^a   Busch, David B ^b   Inui, Hiroki ^a,i   Emmert, Steffen ^a,j   Imoto, Kyoko ^a   Muniz Medina, Vanessa ^a,k   Baker, Carl C ^a   DiGiovanna, John J ^a,c   Schmidt, Deborah ^a   Khadavi, Arash ^a,l   Metin, Ahmet ^d   Gozukara, Engin ^e   Slor, Hanoch ^f   Sarasin, Alain ^g   Kraemer, Kenneth H ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b ARMED FORCES INSTITUTE OF PATHOLOGY   (United States)

^c BROWN UNIVERSITY   (United States)

^d YUZUNCU YIL UNIVERSITY   (Turkey)

^e INONU UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

^f TEL AVIV UNIVERSITY   (Israel)

^g INSTITUT GUSTAVE ROUSSY   (France)

^h Washington and Lee Law School   (United States)

ⁱ KINKI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^j UNIVERSITY OF GÖTTINGEN   (Germany)

^k UNIVERSITY OF NORTH CAROLINA   (United States)

^l UNIVERSITY OF CALIFORNIA   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

DNA; GENE PRODUCT; MESSENGER RNA; UNCLASSIFIED DRUG; XERODERMA PIGMENTOSUM GROUP C PROTEIN;

ADOLESCENT; ADULT; ARTICLE; CANCER RISK; CANCER SUSCEPTIBILITY; CELL LINE; CONTROLLED STUDY; DNA REPAIR; FAMILY STUDY; FEMALE; FRAMESHIFT MUTATION; GENE MUTATION; HETEROZYGOTE; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MALE; NONSENSE MUTATION; PARENT; PRIORITY JOURNAL; QUANTITATIVE ASSAY; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA DEGRADATION; RNA SPLICING; SCHOOL CHILD; SENSITIVITY ANALYSIS; STOP CODON; WESTERN BLOTTING; XERODERMA PIGMENTOSUM;

ADOLESCENT; ADULT; BLOTTING, WESTERN; CHILD; CODON, NONSENSE; DNA PRIMERS; DNA REPAIR; DNA-BINDING PROTEINS; FEMALE; HETEROZYGOTE; HUMANS; INFANT; INFANT, NEWBORN; MALE; MUTATION; PARENTS; POLYMERASE CHAIN REACTION; RNA SPLICE SITES; RNA, MESSENGER; XERODERMA PIGMENTOSUM;

EID: 29744457502     PISSN: 01433334     EISSN: 14602180     Source Type: Journal    
DOI: 10.1093/carcin/bgi204     Document Type: Article

References (61)

1. Bootsma,D., Kraemer,K.H., Cleaver,J.E. and Hoeijmakers,J.H.J. (2002) Nucleotide excision repair syndromes: Xeroderma pigmentosum, Cockayne syndrome, and trichothiodystrophy. In Vogelstein,B. and Kinzler,K.W. (eds) The Genetic Basis of Human Cancer, 2nd edn. McGraw-Hill, New York, pp. 211-237.
2. Kraemer,K.H. (2003) Heritable diseases with increased sensitivity to cellular injury. In Freedberg,I.M., Eisen,A.Z., Wolff, K., Austen,K.F., Goldsmith,L.A. and Katz,S.I. (eds) Fitzpatrick's Dermatology in General Medicine. McGraw-Hill, New York, pp. 1508-1521.
3. Sugasawa,K., Ng,J.M., Masutani,C., Iwai,S., Van der Spek,P.J., Eker,A.P., Hanaoka,F., Bootsma,D. and Hoeijmakers,J.H. (1998) Xeroderma pigmentosum group C protein complex is the initiator of global genome nucleotide excision repair. Mol. Cell, 2, 223-232.
4. Yokoi,M., Masutani,C., Maekawa,T., Sugasawa,K., Ohkuma,Y. and Hanaoka,F. (2000) The Xeroderma pigmentosum group C protein complex XPC-HR23B plays an important role in the recruitment of transcription factor IIH to damaged DNA. J. Biol. Chem., 275, 9870-9875.
5. Okuda,Y., Nishi,R., Ng,J.M., Vermeulen,W., van der Horst,G.T., Mori,T, Hoeijmakers,J.H., Hanaoka,F. and Sugasawa,K. (2004) Relative levels of the two mammalian Rad23 homologs determine composition and stability of the Xeroderma pigmentosum group C protein complex. DNA Repair (Amst), 3, 1285-1295.
6. Nishi,R., Okuda,Y., Watanabe,E., Mori,T., Iwai,S., Masutani,C., Sugasawa,K. and Hanaoka,F. (2005) Centrin 2 stimulates nucleotide excision repair by interacting with Xeroderma pigmentosum group C protein. Mol. Cell Biol., 25, 5664-5674.
7. Popescu,A., Miron,S., Blouquit,Y., Duchambon,P., Christova,P. and Craescu,C.T. (2003) Xeroderma pigmentosum group C protein possesses a high affinity binding site to human centrin 2 and calmodulin. J. Biol. Chem., 278, 4025-40261.
8. Araki,M., Masutani,C., Takemura, M., Uchida,A., Sugasawa,K., Kondoh,J., Ohkuma,Y. and Hanaoka,F. (2001) Centrosome protein centrin 2/caltractin 1 is part of the Xeroderma pigmentosum group C complex that initiates global genome nucleotide excision repair. J. Biol. Chem., 276, 18665-18672.
9. Kraemer,K.H., Lee,M.M. and Scotto,J. (1987) Xeroderma pigmentosum. Cutaneous, ocular, and neurologic abnormalities in 830 published cases. Arch. Dermatol., 123, 241-250.
10. Kraemer,K.H., Lee,M.-M., Andrews,A.D. and Lambert,W.C. (1994) The role of sunlight and DNA repair in melanoma and nonmelanoma skin cancer: The Xeroderma pigmentosum paradigm. Arch. Dermatol., 130, 1018-1021.
11. Swift,M. and Chase,C. (1979) Cancer in families with Xeroderma pigmentosum. J. Natl Cancer Inst., 62, 1415-1421.
12. Sands,A.T., Abuin,A., Sanchez,A., Conti,C.J. and Bradley,A. (1995) High susceptibility to ultraviolet-induced carcinogenesis in mice lacking XPC. Nature, 377, 162-165.
13. Ananthaswamy,H.N., Ouhtit,A., Evans,R.L., Gorny,A., Khaskina,P., Sands,A.T. and Conti,C.J. (1999) Persistence of p53 mutations and resistance of keratinocytes to apoptosis are associated with the increased susceptibility of mice lacking the XPC gene to UV carcinogenesis. Oncogene, 18, 7395-7398.
14. Friedberg,E.C., Cheo,D.L., Meira,L.B. and Reis,A.M. (1999) Cancer predisposition in mutant mice defective in the XPC DNA repair gene. Prog. Exp. Tumor Res., 35, 37-52.
15. Cheo,D.L., Meira,L.B., Burns,D.K., Reis,A.M., Issac,T. and Friedberg,E.C. (2000) Ultraviolet B radiation-induced skin cancer in mice defective in the Xpc, Trp53, and Apex (HAP1) genes: genotype-specific effects on cancer predisposition and pathology of tumors. Cancer Res., 60, 1580-1584.
16. Friedberg,E.C., Bond,J.P., Burns,D.K., Cheo,D.L., Greenblatt,M.S., Meira,L.B., Nahari,D. and Reis,A.M. (2000) Defective nucleotide excision repair in xpc mutant mice and its association with cancer predisposition. Mutat. Res., 459, 99-108.
17. Reis,A.M., Cheo,D.L., Meira,L.B., Greenblatt,M.S., Bond,J.P., Nahari,D. and Friedberg,E.C. (2000) Genotype-specific Trp53 mutational analysis in ultraviolet B radiation-induced skin cancers in Xpc and Xpc Trp53 mutant mice. Cancer Res., 60, 1571-1579.
18. Inga,A., Nahari,D., Velasco-Miguel,S., Friedberg,E.C. and Resnick,M.A. (2002) A novel p53 mutational hotspot in skin tumors from UV-irradiated Xpc mutant mice alters transactivation functions. Oncogene, 21, 5704-5715.
19. Nahari,D., McDaniel,L.D., Task,L.B., Daniel,R.L., Velasco-Miguel,S. and Friedberg,E.C. (2004) Mutations in the Trp53 gene of UV-irradiated Xpc mutant mice suggest a novel Xpc-dependent DNA repair process. DNA Repair (Amst), 3, 379-386.
20. Khan,S.G., Muniz-Medina,V., Shahlavi,T., Baker,C.C., Inui,H., Ueda,T., Emmert,S., Schneider,T.D. and Kraemer,K.H. (2002) The human XPC DNA repair gene: Arrangement, splice site information content and influence of a single nucleotide polymorphism in a splice acceptor site on alternative splicing and function. Nucleic Acids Res., 30, 3624-3631.
21. Khan,S.G., Metin,A., Gozukara,E. et al. (2004) Two essential splice lariat branchpoint sequences in one intron in a Xeroderma pigmentosum DNA repair gene: Mutations result in reduced XPC mRNA levels that correlate with cancer risk. Hum. Mol. Genet., 13, 343-352.
22. Slor,H., Batko,S., Khan,S.G., Sobe,T., Emmert,S., Khadavi,A., Frumkin,A., Busch,D.B., Albert,R.B. and Kraemer,K.H. (2000) Clinical, cellular, and molecular features of an Israeli Xeroderma pigmentosum family with a frameshift mutation in the XPC gene: Sun protection prolongs life. J. Invest Dermatol., 115, 974-980.
23. DiGiovanna,J.J., Patronas,N., Katz,D., Abangan,D. and Kraemer,K.H. (1998) Xeroderma pigmentosum: Spinal cord astrocytoma with 9-year survival after radiation and isotretinoin therapy. J. Cutan. Med. Surg., 2, 153-158.
24. Li,L., Bales,E.S., Peterson,C.A. and Legerski,R.J. (1993) Characterization of molecular defects in Xeroderma pigmentosum group C. Nat. Genet., 5, 413-417.
25. Robbins,J.H., Kraemer,K.H., Merchant,S.N. and Brumback,R.A. (2002) Adult-onset Xeroderma pigmentosum neurological disease - observations in an autopsy case. Clin. Neuropathol., 21, 18-23.
26. Robbins,J.H., Kraemer,K.H., Lutzner,M.A., Festoff, B.W. and Coon,H.G. (1974) Xeroderma pigmentosum. An inherited disease with sun sensitivity, multiple cutaneous neoplasms, and abnormal DNA repair. Ann. Intern. Med., 80, 221-248.
27. Gozukara,E.M., Khan,S.G., Metin,A. et al. (2001) A stop codon in Xeroderma pigmentosum group C families in Turkey and Italy: Molecular genetic evidence for a common ancestor. J. Invest Dermatol., 117, 197-204.
28. Daya-Grosjean,L., James,M.R., Drougard,C. and Sarasin,A. (1987) An immortalized Xeroderma pigmentosum, group C, cell line which replicates SV40 shuttle vectors. Mutat. Res., 183, 185-196.
29. Emmert,S., Slor,H., Busch,D.B. et al. (2002) Relationship of neurologic degeneration to genotype in three Xeroderma pigmentosum group G patients. J. Invest Dermatol., 118, 972-982.
30. Kraemer,K.H., Coon,H.G., Petinga,R.A., Barrett,S.F., Rahe,A.E. and Robbins,J.H. (1975) Genetic heterogeneity in Xeroderma pigmentosum: complementation groups and their relationship to DNA repair rates. Proc. Natl Acad. Sci. USA, 72, 59-63.
31. Sarasin,A., Blanchet-Bardon,C., Renault,G., Lehmann,A., Arlett,C. and Dumez,Y. (1992) Prenatal diagnosis in a subset of trichothiodystrophy patients defective in DNA repair. Br. J. Dermatol., 127, 485-491.
32. Carreau,M., Eveno,E., Quilliet,X., Chevalier-Lagente,O., Benoit,A., Tanganelli,B., Stefanini,M., Vermeulen,W., Hoeijmakers,J.H. and Sarasin,A. (1995) Development of a new easy complementation assay for DNA repair deficient human syndromes using cloned repair genes. Carcinogenesis, 16, 1003-1009.
33. Vandesompele,J., De Preter,K., Pattyn,F., Poppe,B., Van Roy,N., De Paepe,A. and Speleman,F. (2002) Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome Biol., 3, RESEARCH0034. 1-0034.11.
34. Schneider,T.D. (1997) Information content of individual genetic sequences. J. Theor. Biol., 189, 427-441.
35. Schneider,T.D. (1997) Sequence walkers: A graphical method to display how binding proteins interact with DNA or RNA sequences. Nucleic Acids Res., 25, 4408-4415.
36. Emmert,S., Kobayashi,N., Khan,S.G. and Kraemer,K.H. (2000) The Xeroderma pigmentosum group C gene leads to selective repair of cyclobutane pyrimidine dimers rather than 6-4 photoproducts. Proc. Natl Acad. Sci. USA, 97, 2151-2156.
37. Rapin,I., Lindenbaum,Y., Dickson,D.W., Kraemer,K.H. and Robbins,J.H. (2000) Cockayne syndrome and Xeroderma pigmentosum. Neurology, 55, 1442-1449.
38. Khan,S.G., Levy,H.L., Legerski,R. et al. (1998) Xeroderma pigmentosum group C splice mutation associated with autism and hypoglycinemia. J. Invest. Dermatol., 111, 791-796.
39. Giglia,G., Dumaz,N., Drougard,C., Avril,M.F., Daya-Grosjean,L. and Sarasin,A. (1998) p53 Mutations in skin and internal tumors of Xeroderma pigmentosum patients belonging to the complementation group C. Cancer Res., 58, 4402-4409.
40. Giglia,G., Bouffet,E., Jouvet,A., Ohgaki,H., Kleihues,P. and Sarasin,A. (1999) Molecular analysis of glioma and skin-tumour alterations in a Xeroderma-pigmentosum child. Int. J. Cancer, 81, 345-350.
41. Chavanne,F., Broughton,B.C., Pietra,D., Nardo,T., Browitt,A., Lehmann,A.R. and Stefanini,M. (2000) Mutations in the XPC gene in families with Xeroderma pigmentosum and consequences at the cell, protein, and transcript levels. Cancer Res., 60, 1974-1982.
42. Cleaver,J.E., Thompson,L.H., Richardson,A.S. and States,J.C. (1999) A summary of mutations in the UV-sensitive disorders: Xeroderma pigmentosum, Cockayne syndrome, and trichothiodystrophy. Hum. Mutat., 14, 9-22.
43. Khan,S.G., Metter,E.J., Tarone,R.E., Bohr,V.A., Grossman,L., Hedayati,M., Bale,S.J., Emmert,S. and Kraemer,K.H. (2000) A new Xeroderma pigmentosum group C poly(AT) insertion/deletion polymorphism. Carcinogenesis, 21, 1821-1825.
44. Frischmeyer,P.A. and Dietz,H.C. (1999) Nonsense-mediated mRNA decay in health and disease. Hum. Mol. Genet., 8, 1893-1900.
45. Maquat,L.E. (2002) Nonsense-mediated mRNA decay. Curr. Biol., 12, R196-R197.
46. Lejeune,F. and Maquat,L.E. (2005) Mechanistic links between nonsense-mediated mRNA decay and pre-mRNA splicing in mammalian cells. Curr. Opin. Cell Biol., 17, 309-315.
47. Maquat,L.E. (2004) Nonsense-mediated mRNA decay: Splicing, translation and mRNP dynamics. Nat. Rev. Mol. Cell Biol., 5, 89-99.
48. Maquat,L.E. (2005) Nonsense-mediated mRNA decay in mammals. J. Cell Sci., 118, 1773-1776.
49. Legerski,R. and Peterson,C. (1992) Expression cloning of a human DNA repair gene involved in Xeroderma pigmentosum group C [published erratum appears in 1992 Dec 10;360(6404):610]. Nature, 359, 70-73.
50. Mallery,D.L., Tanganelli,B., Colella, S., Steingrimsdottir,H., Van Gool,A.J., Troelstra,C., Stefanini,M. and Lehmarm,A.R. (1998) Molecular analysis of mutations in the CSB (ERCC6) gene in patients with Cockayne syndrome. Am. J. Hum. Genet., 62, 77-85.
51. Lehmarm,A.R. (2001) The Xeroderma pigmentosum group D (XPD) gene: One gene, two functions, three diseases. Genes Dev., 15, 15-23.
52. Sugasawa,K., Okuda,Y., Saijo,M. et al. (2005) UV-induced ubiquitylation of XPC protein mediated by UV-DDB-ubiquitin ligase complex. Cell, 121, 387-400.
53. Shimizu,Y., Iwai,S., Hanaoka,F. and Sugasawa, K. (2003) Xeroderma pigmentosum group C protein interacts physically and functionally with thymine DNA glycosylase. EMBO J., 22, 164-173.
54. Brooks,P.J., Wise,D.S., Berry,D.A. et al. (2000) The oxidative DNA lesion 8,5′-cyclo-2′-deoxyadenosine is repaired by the nucleotide excision repair pathway and blocks gene expression in mammalian cells. J. Biol. Chem., 275, 22355-22362.
55. Kuraoka, I., Bender,C., Romieu,A., Cadet,J., Wood,R.D. and Lindahl,T. (2000) Removal of oxygen free-radical-induced 5′,8-purine cyclodeoxynucleosides from DNA by the nucleotide excision-repair pathway in human cells. Proc. Natl Acad. Sci. USA, 97, 3832-3837.
56. Parshad,R., Sanford,K.K., Kraemer,K.H., Jones,G.M. and Tarone,R.E. (1990) Carrier detection in Xeroderma pigmentosum. J. Clin. Invest., 85, 135-138.
57. O lsen,J.H., Hahnemamnn,J.M., Borresen-Dale,A.L. et al. (2001) Cancer in patients with ataxia-telangiectasia and in their relatives in the nordic countries. J. Natl Cancer Inst., 93, 121-127.
58. Gruber,S.B., Ellis,N.A., Scott,K.K. et al. (2002) BLM heterozygosity and the risk of colorectal cancer. Science, 297, 2013.
59. Shen,H., Sturgis,E.M., Khan,S.G. et al. (2001) An intronic poly (AT) polymorphism of the DNA repair gene XPC and risk of squamous cell carcinoma of the head and neck: A case-control study. Cancer Res., 61, 3321-3325.
60. Marin,M.S., Lopez-Cima,M.F., Garcia-Castro,L., Pascual,T., Marron,M.G. and Tardon,A. (2004) Poly (AT) polymorphism in intron 11 of the XPC DNA repair gene enhances the risk of lung cancer. Cancer Epidemiol. Biomarkers Prev., 13, 1788-1793.
61. Yang,M., Kang,M.J., Choi,Y., Kim,C.S., Lee,S.M., Park,C.W., Lee,H.S. and Tae,K. (2005) Associations between XPC expression, genotype, and the risk of head and neck cancer. Environ. Mol. Mutagen., 45, 374-379.